Nanomedicine for gene therapy

Drug Delivery and Translational Research
Susan Muthe Alex, Chandra P Sharma

Abstract

Viruses are promising vehicles that result in high gene expression level, but issues of safety and virulent nature prevented its extensive use. Therefore, nonviral approach was investigated with the intervention of nanomedicine. The science of nanomedicine offered an excellent platform for therapeutic delivery as they provide options to include functionalities and engineer the system. As the term 'nano' refers to the generation of a very small dimension structure, their unique physicochemical characteristics with increased surface area/volume ratio made them potential vectors to perform gene therapy. Various forms of nanoparticles are continued to be synthesised, and this review discusses the immediate barriers that nanoparticles have to encounter both during systemic movement in the body and intracellular trafficking to deliver the genes at the site of action.

References

Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P L FelgnerM Danielsen
May 22, 1996·Biochimica Et Biophysica Acta·C D OjaP R Cullis
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·O Zelphati, F C Szoka
Jul 14, 1998·Antimicrobial Agents and Chemotherapy·E W van EttenI A Bakker-Woudenberg
Sep 5, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·H LeeT G Park
Nov 15, 2002·Nature·Erika Check
Feb 5, 2003·Advanced Drug Delivery Reviews·Virginie EscriouPierre Wils
May 3, 2003·Nature Reviews. Genetics·Clare E ThomasMark A Kay
Jul 5, 2003·The Journal of Pharmacy and Pharmacology·Yong Woo ChoKinam Park
Nov 16, 2004·The Journal of Gene Medicine·Akin AkincRobert Langer
Feb 22, 2005·Advanced Drug Delivery Reviews·Mattias BeltingAnders Wittrup
Apr 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Mini ThomasAlexander M Klibanov
Jun 7, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mi Ran ParkChong Su Cho
Oct 26, 2005·Biomaterials·Laura De LaporteLonnie D Shea
Nov 22, 2005·Advanced Drug Delivery Reviews·Ruth Duncan, Lorella Izzo
Mar 2, 2006·Pharmacological Reviews·Ikramy A KhalilHideyoshi Harashima
Aug 22, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Tracy R DanielsManuel L Penichet
Nov 16, 2006·Bioconjugate Chemistry·Devika Soundara Manickam, David Oupický
Dec 16, 2006·International Journal of Pharmaceutics·Archana SwamiK C Gupta
Jan 24, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yong HuChi-Hwa Wang
Feb 3, 2007·Proceedings of the National Academy of Sciences of the United States of America·Tommy CedervallSara Linse
Jun 9, 2007·Expert Opinion on Biological Therapy·Garrett R Rettig, Kevin G Rice
Aug 19, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Luis ApoloniaNicola J Philpott
Sep 1, 2007·Journal of Cellular and Molecular Medicine·Arwyn Tomos Jones
Sep 4, 2007·Toxicology and Applied Pharmacology·Tisha C King HeidenRichard E Peterson
Oct 13, 2007·Pharmaceutical Research·Jamie M BergenSuzie H Pun
Dec 22, 2007·Expert Opinion on Drug Delivery·David B Fenske, Pieter R Cullis
Jan 19, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jordy LutenWim E Hennink
May 27, 2008·Nature Structural & Molecular Biology·Katsutomo OkamuraEric C Lai
Jul 26, 2008·Nature Nanotechnology·Marina A Dobrovolskaia, Scott E McNeil
Oct 9, 2008·Advanced Drug Delivery Reviews·James D ByrneLisa Brannon-Peppas
Oct 22, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Young Tag KoVladimir P Torchilin
Mar 3, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marika RuponenVeli-Pekka Ranta
Mar 31, 2009·Advanced Drug Delivery Reviews·Yu-Cheng TsengLeaf Huang
Apr 1, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hae Yun NamSeo Young Jeong
May 1, 2009·Nature Cell Biology·Jason Mercer, Ari Helenius
Jun 9, 2009·International Journal of Pharmaceutics·Dhananjay JereChong-Su Cho

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Chemical Reviews
Meredith A Mintzer, Eric E Simanek
International Journal of Pharmaceutical Investigation
Ningning Yang
Ernst Schering Research Foundation Workshop
J A Wolff, H Herweijer
Current Pharmaceutical Design
Bing Yan
© 2021 Meta ULC. All rights reserved